Actively Recruiting
Evaluation of the Impact of Visual Rehabilitation on Anxiety and Depression Severity in Visually Impaired Patients With Advanced Age-Related Macular Degeneration
Led by Fondazione G.B. Bietti, IRCCS · Updated on 2026-06-01
22
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
F
Fondazione G.B. Bietti, IRCCS
Lead Sponsor
S
Sant'Alessio - Margherita di Savoia
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are evaluating how a visual rehabilitation program affects anxiety and depression in patients with advanced age-related macular degeneration (AMD) who have moderate to severe visual impairment. This observational study aims to understand the emotional impact of vision loss and how rehabilitation may influence patients' mental health by using questionnaires to assess anxiety and depression. The study involves a 60-day visual rehabilitation program delivered through five group meetings. These sessions include activities such as coin recognition, reading and listening to stories, installing and using apps and voice assistants on smartphones and tablets, managing table activities, and a meeting involving caregivers. The program is designed to support visually impaired patients in their daily life skills. Participants will have three main visits: a screening visit with ophthalmological exams and anxiety and depression questionnaires, the rehabilitation program across five group meetings, and an end-of-study visit with repeated eye exams and questionnaire assessments. The study measures changes in anxiety and depression levels over 12 weeks. All assessments include non-invasive tests like optical coherence tomography and microperimetry to monitor eye health throughout the study.
CONDITIONS
Brief Title
Visual Rehabilitation and Depression in Visually Impaired Patients With AMD
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Subjects 55 years or older
- Moderate to severe visual impairment with best corrected visual acuity between 1/10 and 2/10
- Diagnosis of advanced non-exudative age-related macular degeneration (AMD)
- Informed consent freely given before starting the study
- Ability to understand and willingness to follow study instructions and procedures
You will not qualify if you...
- Visual impairment caused by other eye diseases
- Mild visual impairment or partial or total blindness
- Exudative age-related macular degeneration currently treated with intravitreal drugs
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 12 weeks
Participants attend a series of meetings focusing on coin recognition, reading stories and audiobooks, installing and using apps with voice assistants, managing table activities, and meeting with caregivers.
5 visits (in-person)
Trial Site Locations
Total: 1 location
1
IRCCS Fondazione G.B.Bietti
Rome, Italy, Italy, 00184
Actively Recruiting
Research Team
E
Eliana Costanzo, MD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here